Fresenius SE & Co. (OTCMKTS:FSNUY) Shares Gap Up – Here’s Why

Posted by Michael Walen on Sep 8th, 2026

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report)’s share price gapped up before the market opened on Tuesday . The stock had previously closed at $12.72, but opened at $13.53. Fresenius SE & Co. shares last traded at $13.11, with a volume of 3,363 shares.

Analysts Set New Price Targets

Several equities analysts have weighed in on the company. Morgan Stanley reaffirmed an “overweight” rating on shares of Fresenius SE & Co. in a report on Tuesday, July 21st. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Fresenius SE & Co. in a report on Thursday, August 6th. Three research analysts have rated the stock with a Buy rating, According to MarketBeat.com, Fresenius SE & Co. has a consensus rating of “Buy”.

Check Out Our Latest Research Report on FSNUY

Fresenius SE & Co. Stock Up 2.5%

The firm’s 50-day moving average price is $12.84 and its 200 day moving average price is $12.58. The company has a current ratio of 1.27, a quick ratio of 0.98 and a debt-to-equity ratio of 0.41. The company has a market capitalization of $29.37 billion, a price-to-earnings ratio of 16.50 and a beta of 0.62.

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) last posted its quarterly earnings results on Wednesday, August 5th. The company reported $0.24 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.01). The firm had revenue of $6.91 billion for the quarter, compared to analyst estimates of $6.65 billion. Fresenius SE & Co. had a return on equity of 10.33% and a net margin of 6.67%. On average, sell-side analysts forecast that Fresenius SE & Co. will post 1.08 EPS for the current fiscal year.

About Fresenius SE & Co.

(Get Free Report)

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.